Viewing Study NCT04991961


Ignite Creation Date: 2025-12-24 @ 12:16 PM
Ignite Modification Date: 2025-12-27 @ 10:08 PM
Study NCT ID: NCT04991961
Status: COMPLETED
Last Update Posted: 2025-08-14
First Post: 2021-07-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism
Sponsor: Chongqing Medical University
Organization:

Study Overview

Official Title: Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism:a Prospective Study
Status: COMPLETED
Status Verified Date: 2020-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HASA
Brief Summary: To evaluate the effect of anti-hypertensive medication on efficiency of primary aldosteronism screening and confirmatory test, and to determine the appropriate diagnostic cutoff value for Chinese hypertension patients during antihypertensive drugs therapy.
Detailed Description: Aldosterone-Renin ratio (ARR)is currently the most reliable means available for screening for primary aldosterone(PA)while captopril challenging test is the widely used confirmatory test. However, some antihypertensive drugs may interfer aldosterone and renin levels. Thus, PA guidelines suggest that antihypertensive drugs should be withdraw or change therapy before screening.

But withdraw/changing the therapy is inconvenient for patients.

The investigators prepare to start a prospective study through recruiting hypertension patients, completing the ARR screening and captopril challenging test before and after withdraw/change therapy.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: